Clinical Trial Results

Showing: All studies [change]
Condition: Lupus Location: Scottsdale, Arizona 11 trials found
New Search
Filter
Trial Phase
Study Type
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Avondale, Arizona +4 more
RECRUITING
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
PHASE4INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
PHASE1INTERVENTIONAL Avondale, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type